Titrating CD47 by mismatch CRISPR-interference reveals incomplete repression can eliminate IgG-opsonized tumors but limits induction of antitumor IgG
Open Access
- 27 July 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 2 (8) , pgad243
Abstract
Phagocytic elimination of solid tumors by innate immune cells seems attractive for immunotherapy, particularly because of the possibilities for acquired immunity. However, the approach remains challenging, with blockade of the macrophage checkpoint CD47 working in immunodeficient mice and against highly immunogenic tumors but not in the clinic where tumors are poorly immunogenic. Even when mouse tumors of poorly immunogenic B16F10 melanoma are opsonized to drive engulfment with a suitable monoclonal antibody (mAb), anti-CD47 blockade remains insufficient. Using both in vitro immuno-tumoroids and in vivo mouse models, we show with CRISPR-interference (CRISPRi) that a relatively uniform minimum repression of CD47 by 80% is needed for phagocytosis to dominate net growth when combined with an otherwise ineffective mAb (anti-Tyrp1). Mice that eliminate tumors generate pro-phagocytic IgGs that increase in titer with CD47 repression and with tumor accumulation of macrophages, although greater repression does not improve survival. Given well-known limitations of antibody permeation into solid tumors, our studies clarify benchmarks for CD47 disruption that should be more clinically feasible and safer but just as effective as complete ablation. Additionally, safe but ineffective opsonization in human melanoma trials suggests that combinations with deep repression of CD47 could prove effective and initiate durable immunity.Keywords
Funding Information
- NIH (U01CA254886 (D.E.D.), R01 HL124106 (D.E.D.))
- NSF (GRFP DGE-1845298 (B.H.H. and J.C.A.))
- NIH (F32 CA228285 (L.J.D.))
This publication has 47 references indexed in Scilit:
- Genome-Scale CRISPR-Mediated Control of Gene Repression and ActivationCell, 2014
- The Antigen Presenting Cells Instruct Plasma Cell DifferentiationFrontiers in Immunology, 2014
- Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to ImmunotherapyJournal of Immunotherapy, 2013
- Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma MetastasesCancer Research, 2012
- Properties of mouse and human IgG receptors and their contribution to disease modelsBlood, 2012
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumorsProceedings of the National Academy of Sciences, 2012
- FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivoProceedings of the National Academy of Sciences, 2010
- CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid PhagocytosisCell, 2009
- Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cellsJournal of Cell Biology, 2008
- Role of CD47 as a Marker of Self on Red Blood CellsScience, 2000